Gene set enrichment analysis of gene signatures in STAT3-high ABC DLBCL versus STAT3-low ABC DLBCL cases
Short signature name . | Signature description . | Number of coregulated genes . | Permutation P value . | Reference . |
---|---|---|---|---|
NF-κB-2 | NF-κB: OCILy3 and OCI-Ly10 | 30 | .001 | 41 |
NF-κB-1 | NF-κB: OCILy3 or OCI-Ly10 | 40 | .001 | 41 |
Proliferation-7 | Cell cycle | 99 | .001 | 41 |
IL-6 | IL-6 targets | 22 | .003 | Current study |
IL-10 | IL-10 targets | 47 | .003 | Current study |
Glycolysis | Glycolytic enzymes | 5 | .003 | 60 |
Proliferation-5 | Proliferation: DLBCL | 615 | .007 | 4 |
Proliferation-8 | Cell cycle | 136 | .01 | 42 |
Short signature name . | Signature description . | Number of coregulated genes . | Permutation P value . | Reference . |
---|---|---|---|---|
NF-κB-2 | NF-κB: OCILy3 and OCI-Ly10 | 30 | .001 | 41 |
NF-κB-1 | NF-κB: OCILy3 or OCI-Ly10 | 40 | .001 | 41 |
Proliferation-7 | Cell cycle | 99 | .001 | 41 |
IL-6 | IL-6 targets | 22 | .003 | Current study |
IL-10 | IL-10 targets | 47 | .003 | Current study |
Glycolysis | Glycolytic enzymes | 5 | .003 | 60 |
Proliferation-5 | Proliferation: DLBCL | 615 | .007 | 4 |
Proliferation-8 | Cell cycle | 136 | .01 | 42 |